![Medicom Medical Publishers on Twitter: "Can't go to a Conference? Medicom pledges support to physicians affected by #COVID19 by offering free access to our entire Conference Reports library until end June 2020. Medicom Medical Publishers on Twitter: "Can't go to a Conference? Medicom pledges support to physicians affected by #COVID19 by offering free access to our entire Conference Reports library until end June 2020.](https://pbs.twimg.com/media/ESMzJWGXkAE7pWk.jpg)
Medicom Medical Publishers on Twitter: "Can't go to a Conference? Medicom pledges support to physicians affected by #COVID19 by offering free access to our entire Conference Reports library until end June 2020.
![PDF) P011 Signalling and transcriptional network propagation uncovers novel ulcerative colitis pathogenetic pathways from single-nucleotide polymorphisms PDF) P011 Signalling and transcriptional network propagation uncovers novel ulcerative colitis pathogenetic pathways from single-nucleotide polymorphisms](https://i1.rgstatic.net/publication/330643377_P011_Signalling_and_transcriptional_network_propagation_uncovers_novel_ulcerative_colitis_pathogenetic_pathways_from_single-nucleotide_polymorphisms/links/5c805057458515831f8b1692/largepreview.png)
PDF) P011 Signalling and transcriptional network propagation uncovers novel ulcerative colitis pathogenetic pathways from single-nucleotide polymorphisms
![PDF) P460 Efficacy of ustekinumab in patients with anti-TNF refractory Crohn's disease: data from a real-world study in Brazil PDF) P460 Efficacy of ustekinumab in patients with anti-TNF refractory Crohn's disease: data from a real-world study in Brazil](https://i1.rgstatic.net/publication/330642832_P460_Efficacy_of_ustekinumab_in_patients_with_anti-TNF_refractory_Crohn's_disease_data_from_a_real-world_study_in_Brazil/links/5f39403492851cd302faa3a3/largepreview.png)